BlackRock Investment Management’s Allergan plc AGN.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN.PRA
BFA
BA
LCM
O
BlackRock Investment Management's AGN.PRA Position: Q4 2016 in Review
BlackRock Investment Management reduced its Allergan plc (AGN.PRA) stake by 7.3% in Q4 2016, selling an estimated $843K and leaving 14,161 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1072.
BlackRock Investment Management first reported a position in AGN.PRA in Q3 2015 and has held it in 6 quarters since. The position peaked at $19.8M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.
- BlackRock Investment Management held 14,161 shares of Allergan plc worth $10.8M as of Q4 2016.
- BlackRock Investment Management sold 1,115 Allergan plc shares in Q4 2016, an estimated $843K.
- Allergan plc made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1072 holding.
- BlackRock Investment Management first reported a position in Allergan plc in Q3 2015 and has held it in 6 quarters since.
- BlackRock Investment Management's Allergan plc position peaked at $19.8M in Q4 2015.
- 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.